ArticleBiomolecules2022
An Efficient Lightweight Hybrid Model with Attention Mechanism for Enhancer Sequence Recognition.
Article in Biomolecules, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- DeepEnhancerPPO: An Interpretable Deep Learning Approach for Enhancer Classification.International journal of molecular sciences · 2024Article
- MedicalCLIP: Anomaly-Detection Domain Generalization with Asymmetric Constraints.Biomolecules · 2024Article
- Enhancer Recognition: A Transformer Encoder-Based Method with WGAN-GP for Data Augmentation.International journal of molecular sciences · 2023Article
- Solar Power Prediction Using Dual Stream CNN-LSTM Architecture.Sensors (Basel, Switzerland) · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Enhancers are sequences with short motifs that exhibit high positional variability and free scattering properties. Identification of these noncoding DNA fragments and their strength are extremely important because they play a key role in controlling gene regulation on a cellular basis. The identification of enhancers is more complex than that of other factors in the genome because they are freely scattered, and their location varies widely. In recent years, bioinformatics tools have enabled significant improvement in identifying this biological difficulty. Cell line-specific screening is not possible using these existing computational methods based solely on DNA sequences. DNA segment chromatin accessibility may provide useful information about its potential function in regulation, thereby identifying regulatory elements based on its chromatin accessibility. In chromatin, the entanglement structure allows positions far apart in the sequence to encounter each other, regardless of their proximity to the gene to be acted upon. Thus, identifying enhancers and assessing their strength is difficult and time-consuming. The goal of our work was to overcome these limitations by presenting a convolutional neural network (CNN) with attention-gated recurrent units (AttGRU) based on Deep Learning. It used a CNN and one-hot coding to build models, primarily to identify enhancers and secondarily to classify their strength. To test the performance of the proposed model, parallels were drawn between enhancer-CNNAttGRU and existing state-of-the-art methods to enable comparisons. The proposed model performed the best for predicting stage one and stage two enhancer sequences, as well as their strengths, in a cross-species analysis, achieving best accuracy values of 87.39% and 84.46%, respectively. Overall, the results showed that the proposed model provided comparable results to state-of-the-art models, highlighting its usefulness.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.